India · Delayed Price · Currency is INR Hester Biosciences Statistics
Total Valuation
NSE:HESTERBIO has a market cap or net worth of INR 12.15 billion. The enterprise value is 14.33 billion.
| Market Cap | 12.15B |
| Enterprise Value | 14.33B |
Important Dates
The next confirmed earnings date is Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | Aug 6, 2025 |
Share Statistics
| Current Share Class | 8.51M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | -6.57% |
| Owned by Insiders (%) | 63.75% |
| Owned by Institutions (%) | 0.28% |
| Float | 2.66M |
Valuation Ratios
The trailing PE ratio is 29.67.
| PE Ratio | 29.67 |
| Forward PE | n/a |
| PS Ratio | 3.85 |
| PB Ratio | 3.46 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.01 |
| EV / Sales | 4.54 |
| EV / EBITDA | 18.42 |
| EV / EBIT | 23.29 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 2.97 |
| Debt / FCF | n/a |
| Interest Coverage | 7.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.80% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.20% |
| Revenue Per Employee | 5.62M |
| Profits Per Employee | 728,594 |
| Employee Count | 562 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:HESTERBIO has paid 120.14 million in taxes.
| Income Tax | 120.14M |
| Effective Tax Rate | 22.05% |
Stock Price Statistics
The stock price has decreased by -4.67% in the last 52 weeks. The beta is 0.04, so NSE:HESTERBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -4.67% |
| 50-Day Moving Average | 1,473.44 |
| 200-Day Moving Average | 1,711.62 |
| Relative Strength Index (RSI) | 49.19 |
| Average Volume (20 Days) | 5,847 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HESTERBIO had revenue of INR 3.16 billion and earned 409.47 million in profits. Earnings per share was 47.83.
| Revenue | 3.16B |
| Gross Profit | 2.28B |
| Operating Income | 557.35M |
| Pretax Income | 544.92M |
| Net Income | 409.47M |
| EBITDA | 718.13M |
| EBIT | 557.35M |
| Earnings Per Share (EPS) | 47.83 |
Balance Sheet
The company has 79.38 million in cash and 2.14 billion in debt, with a net cash position of -2.06 billion.
| Cash & Cash Equivalents | 79.38M |
| Total Debt | 2.14B |
| Net Cash | -2.06B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.51B |
| Book Value Per Share | 394.06 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 160.78M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 72.21%, with operating and profit margins of 17.65% and 12.97%.
| Gross Margin | 72.21% |
| Operating Margin | 17.65% |
| Pretax Margin | 17.26% |
| Profit Margin | 12.97% |
| EBITDA Margin | 22.74% |
| EBIT Margin | 17.65% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 0.56%.
| Dividend Per Share | 7.00 |
| Dividend Yield | 0.56% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.58% |
| Shareholder Yield | 1.14% |
| Earnings Yield | 3.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |